T. Rowe Price Associates’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-753,595
| Closed | -$1.4M | – | 3005 |
|
|
2022
Q3 | $1.4M | Sell |
753,595
-532,729
| -41% | -$986K | ﹤0.01% | 1596 |
|
|
2022
Q2 | $3.95M | Sell |
1,286,324
-530,235
| -29% | -$1.63M | ﹤0.01% | 1448 |
|
|
2022
Q1 | $13.1M | Sell |
1,816,559
-1,395,916
| -43% | -$10.1M | ﹤0.01% | 1325 |
|
|
2021
Q4 | $52.1M | Buy |
3,212,475
+1,545,784
| +93% | +$25.1M | ﹤0.01% | 989 |
|
|
2021
Q3 | $16.6M | Sell |
1,666,691
-1,942
| -0.1% | -$19.3K | ﹤0.01% | 1343 |
|
|
2021
Q2 | $16.7M | Sell |
1,668,633
-42,222
| -2% | -$422K | ﹤0.01% | 1340 |
|
|
2021
Q1 | $17M | Buy |
+1,710,855
| New | +$17M | ﹤0.01% | 1309 |
|